Pathogenic interplay between markedly elevated plasma lipoprotein(a) levels and prothrombotic mechanisms: a case report
Frontiers in Cardiovascular Medicine · 01.05.2026 · 13
DOI: 10.3389/fcvm.2026.1739634 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 01.05.2026. Verfasst von Marta Biolo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, First Chair of Internal Medicine, Padova University Hospital - School of Medicine, Padova, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lipoprotein(a) [Lp(a)] is a well-established genetic risk factor for atherosclerotic cardiovascular disease, though its role as a prothrombotic risk factor remains only partially understood. We report the case of a 64-year-old woman with markedly elevated Lp(a) levels (925 nmol/L, reference range < 105 nmol/L) and a history of recurrent major cardiovascular events, despite optimal lipid-lowering and antiplatelet therapies. We confirmed a hypercoagulable profile via comprehensive functional assessment of hemostasis: enhanced thrombin generation, reduced sensitivity to thrombomodulin, platelet hyperreactivity, and increased clot firmness at thromboelastometry — with residual platelet activity despite antiplatelet treatment. This case suggests a possible association between markedly elevated plasma Lp(a) levels and a hypercoagulable profile, which may enhance atherogenesis. Global coagulation and platelet function assays may help identify high-risk patients with elevated Lp(a) levels who may benefit from tailored antithrombotic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, First Chair of Internal Medicine, Padova University Hospital - School of Medicine, Padova, Italy.
Zitieren
APA
Biolo, M., Napolitano, A., Spiezia, L., Bulato, C., Toffanin, S., Regazzo, D., Portinari, C., Zambon, A., & Simioni, P. (2026). Pathogenic interplay between markedly elevated plasma lipoprotein(a) levels and prothrombotic mechanisms: a case report. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1739634
Vancouver
Biolo M, Napolitano A, Spiezia L, Bulato C, Toffanin S, Regazzo D, et al. Pathogenic interplay between markedly elevated plasma lipoprotein(a) levels and prothrombotic mechanisms: a case report. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1739634
BibTeX
@article{Biolo2026,
author = {Biolo, Marta and Napolitano, Angela and Spiezia, Luca and Bulato, Cristiana and Toffanin, Serena and Regazzo, Daniela and Portinari, Camilla and Zambon, Alberto and Simioni, Paolo},
title = {Pathogenic interplay between markedly elevated plasma lipoprotein(a) levels and prothrombotic mechanisms: a case report},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1739634}
}
EUVIMED